Cargando…

POS-870 NGAL and microalbuminuria as AKi biomarkers in COVID-19 hospitalized patients with pneumonia

Detalles Bibliográficos
Autores principales:	Rizo Topete MD, L., Enriquez, V., Adrián, C., Victor, E., Flores, R., Barbosa, L.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854957/ http://dx.doi.org/10.1016/j.ekir.2022.01.908

Ejemplares similares

POS-868 THE USE OF OXIRIS MEMBRANE IN CRITICAL ILL PATIENTS WITH SARS COV-2 PNEUMONIA
por: Rizo Topete MD, L., et al.
Publicado: (2022)

POS-049 SUCCESSFUL MULTI ORGAN SUPPORT THERAPY (MOST) IN COVID-19 PNEUMONIA: A CASE REPORT
por: Rizo Topete MD, L., et al.
Publicado: (2021)

POS-869 The early Urinary sediment performance in the hospitalization in patients with COVID-19 and the Nephrology early intervention
por: Rizo Topete MD, L., et al.
Publicado: (2022)

POS-048 RENAL RECOVERY FROM ACUTE KIDNEY DISEASE SECONDARY OF COVID-19 PNEUMONIA WITH CONTINUOUS RENAL REPLACEMENT THERAPY AND TRANSITIONAL HYBRID THERAPY, A SUCCESS CASE REPORT
por: Rizo Topete MD, L., et al.
Publicado: (2021)

POS-047 INCIDENCE OF ACUTE KIDNEY INJURY IN A COVID-19 HOSPITAL IN THE NORTH OF MEXICO
por: Rizo Topete MD, L., et al.
Publicado: (2021)

Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
por: Parikh, Amay, et al.
Publicado: (2017)

Sepsis and AKI in Clinical Emergency Room Patients: The Role of Urinary NGAL
por: Si Nga, Hong, et al.
Publicado: (2015)

Correction: Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
por: Parikh, Amay, et al.
Publicado: (2017)

IL-10 Combined with NGAL Has Diagnostic Value for AECOPD Combined with AKI
por: Wei, Bing, et al.
Publicado: (2020)

Significant microalbuminuria, on admission to the ICU, may indicate AKI in patients with sepsis
por: Basu, S, et al.
Publicado: (2010)

NGAL: an emerging tool for predicting severity of AKI is easily detected by a clinical assay
por: Gabbard, Wes, et al.
Publicado: (2010)

POS-326 AKI IS A USEFUL PREDICTOR OF POOR OUTCOMES IN COVID-19
por: JACKSON, D., et al.
Publicado: (2021)

POS-012 RISK FACTORS FOR AKI AND MORTALITY IN COVID-19 IN WESTERN MEXICO
por: GARCIA RIVERA, A., et al.
Publicado: (2022)

Urine NGAL as a biomarker for septic AKI: a critical appraisal of clinical utility—data from the observational FINNAKI study
por: Törnblom, Sanna, et al.
Publicado: (2020)

Clinical Implementation of NGAL Testing to Improve Diagnostic Assessment of AKI Episodes in a Canadian Center
por: Côté, Jean-Maxime, et al.
Publicado: (2022)

Microalbuminuria and Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL) in Human Immunodeficiency Virus Infected Children
por: Rahiman, Emine A., et al.
Publicado: (2022)

Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels
por: Matsuura, Ryo, et al.
Publicado: (2018)

Urine Neutrophil Gelatinase-associated Lipocalin (NGAL) for Prediction of Persistent AKI and Major Adverse Kidney Events
por: Lumlertgul, Nuttha, et al.
Publicado: (2020)

NGAL/hepcidin-25 ratio and AKI subtypes in patients following cardiac surgery: a prospective observational study
por: Elitok, Saban, et al.
Publicado: (2021)

Serum NGAL, KIM-1, IL-18, L-FABP: new biomarkers in the diagnostics of acute kidney injury (AKI) following invasive cardiology procedures
por: Zdziechowska, Magdalena, et al.
Publicado: (2020)

Plasma neutrophil gelatinase-associated lipocalin (NGAL): A candidate biomarker to detect early acute kidney injury (AKI) for at-risk intensive care admissions
por: Nath, Chandan Kr, et al.
Publicado: (2022)

The utility of neutrophil gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients
por: Khawaja, Shabnum, et al.
Publicado: (2019)

Microalbuminuria: a biomarker of sepsis
por: Basu, S, et al.
Publicado: (2009)

Utility of plasma NGAL for the diagnosis of AKI following cardiac surgery requiring cardiopulmonary bypass: a systematic review and meta-analysis
por: Sharrod-Cole, Hayley, et al.
Publicado: (2022)

POS-027 Critical illness and systemic inflammation are key risk factors of severe AKI in patients with COVID-19
por: HARDENBERG, J.H.B., et al.
Publicado: (2021)

870. Plasma microbial cell-free DNA sequencing impacts antimicrobial management in immunocompromised patients with pneumonia
por: Madut, Deng B, et al.
Publicado: (2023)

Microalbuminuria: A novel biomarker of sepsis
por: Basu, Surupa, et al.
Publicado: (2010)

Value of plasma neutrophil gelatinase-associated lipocalin (NGAL) in distinguishing between acute kidney injury (AKI) and chronic kidney disease (CKD)
por: Corbacıoglu, Seref Kerem, et al.
Publicado: (2017)

Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department
por: Walls, Anne Byriel, et al.
Publicado: (2021)

POS-018 INCIDENCE OF AKI IN HOSPITALIZED COVID 19 PATIENTS – EXPERIENCE FROM A SINGLE TERTIARY CENTER FROM RURAL INDIA
por: Srinivasan, G., et al.
Publicado: (2022)

Microalbuminuria evaluated as a biomarker in patients with septic shock
por: Grion, C, et al.
Publicado: (2010)

Report about fire in building 870 / BA 3
Publicado: (1997)

Report about fire in building 870 / BA 3
Publicado: (1997)

Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study)
por: Ribitsch, Werner, et al.
Publicado: (2017)

POS-206 INCIDENCE AND EARLY PREDICTORS OF AKI IN COVID 19 PATIENTS IN A TERTIARY CARE CENTRE : A RETROSPECTIVE STUDY
por: R, B., et al.
Publicado: (2021)

POS-081 Cytokine storm and secondary bacterial infections in COVID-19 patients with AKI: A multi-center retrospective study
por: MENG, Y., et al.
Publicado: (2021)

POS-014 THE RELATIONSHIP BETWEEN IL-6, IL-10, TNF-α WITH AKI IN MODERATE AND SEVERE COVID-19 PATIENTS
por: Maruhum Bonar, M., et al.
Publicado: (2022)

POS-860 Correlation of AKI with risk factors, ventilatory support, renal replacement therapy in a cohort of COVID-19 patients
por: MOGGA, P., et al.
Publicado: (2022)

Advances in the study of subclinical AKI biomarkers
por: Zou, Chenchen, et al.
Publicado: (2022)

Evaluation of plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) as an early diagnostic marker of acute kidney injury (AKI) in critically ill trauma patients
por: Gupta, Babita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m4rubicq018i4da8kkkj7r9jk0